Sequenex
Sequenex provides the NEX software platform, a regulatory-ready foundation for connected medical devices including CGM, biosensors, and wearables, sold primarily to early- and growth-stage MedTech startups via its MedTech Innovator accelerator partnership.
- Company typePrivate
- Founded2020
- HeadquartersSan Diego, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Sequenex does
Sequenex is a private SaMD and digital health software vendor founded in 2020, operating with a headcount of 11-50 employees. The company's sole commercial product is the NEX software platform, a regulatory-ready stack purpose-built for connected medical devices including continuous glucose monitors (CGM), biosensors, and wearables. Sequenex positions NEX as a compliance-first foundation that helps MedTech developers avoid re-engineering software for FDA-style regulatory submissions, with embedded safety and security architecture aimed at accelerating product development timelines.
Sequenex serves two customer tiers within MedTech: early-stage startups that need compliant software infrastructure from inception, and growth-stage companies that need to scale regulatory-ready connected devices toward market entry. Customer engagement is horizontally segmented by company stage rather than by clinical vertical, with CGM, biosensors, and wearables named as the priority device categories.
The go-to-market model is channel-led. In May 2026 Sequenex announced a flagship partnership with MedTech Innovator (MTI), the world's largest medical technology accelerator, under which Sequenex provides the NEX platform to the 65 startups selected for MTI's 2026 cohort (the top 4% of 1,835 global applicants) and engages those companies at the Radar Forum, Innovator Summit, and Finals Competitions. Sequenex also provides financial sponsorship to MTI, suggesting the partnership has both commercial and ecosystem-marketing dimensions. Pricing is not publicly disclosed and the revenue model is consistent with subscription or platform licensing, though no specific contract terms or named enterprise customers are available in the source data. Leadership is a two-person public profile — CEO Amy Neckermann and CTO/CXO John Krlin — consistent with a venture-scale company still in early commercialization.
Sequenex firmographics
Firmographics- Name
- Sequenex
- Website
- https://sequenex.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Sequenex provides the NEX software platform, a regulatory-ready foundation for connected medical devices including CGM, biosensors, and wearables, sold primarily to early- and growth-stage MedTech startups via its MedTech Innovator accelerator partnership.
- Ownership category
- akta.pro rank
Sequenex industry classification
Industry- Product category
- Medical Device Software (SaMD)
- NAICS
- Computer Systems Design Services (541512)
- SIC
- Services-Computer Programming Services (7371)
- akta.pro primary industry
- Training & Competency Programs for GxP Compliance (HLAGAKAM)
- akta.pro secondary industry
- Testing, Inspection, Certification & Commissioning (TICx) Technical Services (BPAHAIAL)
Keywords
Where Sequenex is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Markets served
Sequenex business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Revenue model
- Software Platform Licensing: Provides regulatory-ready NEX software platform to MedTech startups, likely through licensing or subscription model embedded in the accelerator partnership
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Sequenex product offering
Product offeringCore offering
Sequenex develops and licenses the NEX software platform, a regulatory-ready software solution for connected medical devices including continuous glucose monitors (CGM), biosensors, and wearables. The platform is designed to help early- and growth-stage MedTech companies build, scale, and achieve regulatory compliance for their connected device software faster than developing in-house.
Product overview
Sequenex offers the NEX software platform as its core product — a regulatory-ready software solution for connected medical devices. The platform specifically supports continuous glucose monitoring (CGM) devices, biosensors, and wearables, providing scalable and compliant software development capabilities for early- and growth-stage MedTech companies.
Differentiator
Problem solved
Functional benefit
Products and services
- NEX Software Platform Regulatory-ready software platform for connected medical devices, including continuous glucose monitors (CGM), biosensors, and wearables, designed to support early- and growth-stage MedTech companies with compliant, scalable software development.
Companies that use Sequenex
Customer profileSegments2 records
Ideal customer profiles2 records
Sequenex technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Sequenex partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- MedTech Innovator (MTI)flagshipSequenex partnered with MedTech Innovator, the world's largest medical technology accelerator, to support early- and growth-stage MedTech companies. Under the partnership, Sequenex provides its regulatory-ready NEX software platform for connected medical devices including CGM, biosensors, and wearables, while also providing financial support to MTI. Sequenex engages with cohort companies at critical inflection points throughout the year, including the Radar Forum, Innovator Summit, and Finals Competitions in October.
Scale indicators3 records
Recent moves4 records
Expansion highlights4 records
Sequenex competitors and assessment
Company assessmentBroad incumbents
- Veeva Systems: Industry-standard cloud software for life sciences, with expanding footprint in medical device and clinical operations. A potential incumbent threat as it extends into MedTech regulatory workflows.
- MasterControl: Established quality and manufacturing software platform for life sciences and medical device companies, offering regulatory compliance and QMS tools at greater scale than Sequenex.
- IQVIA: Global life sciences technology and services provider with a regulated platform layer for connected health and medical devices. Competes indirectly as a scaled alternative.
- Medidata Solutions (Dassault Systèmes): Clinical trial and digital health platform serving biopharma and medical device developers. Overlaps with Sequenex in regulated software infrastructure for clinical-stage connected devices.
- Philips HealthSuite: Enterprise cloud platform for connected health devices and patient data, including regulated device enablement. Represents the type of large incumbent Sequenex must differentiate against.
Direct peers
- Greenlight Guru: Quality management system (QMS) and product lifecycle software purpose-built for medical device companies, including connected devices. Competes with Sequenex in regulatory and compliance enablement for MedTech.
- BrightInsight: Provides a regulated digital health platform for biopharma and medtech companies building connected drug delivery, medical devices, and combination products. Closest direct competitor to Sequenex in regulated software infrastructure for connected medical devices.
Emerging players
- ComplianceQuest: Cloud-based QMS and compliance platform with dedicated medical device capabilities. Targets similar MedTech compliance use cases as Sequenex from a broader enterprise quality angle.
- Qualio: Cloud QMS platform focused on life sciences startups and mid-market medical device companies. Closely comparable to Sequenex in targeting early- and growth-stage MedTech.
Regional players
- Forma Medical Affairs (Regulatory Software Division): Regulatory and quality software services for medical device companies, with a more consulting-led model. Comparable as a regulatory-software peer for connected medical devices.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks4 records
Key highlights5 records
Customer concentration
Sequenex social profiles
Digital presenceSequenex financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sequenex leadership team
Management profileNumber of profiles
Profiles2 records
Sequenex funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sequenex M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sequenex
What does Sequenex do?
Sequenex develops and licenses the NEX software platform, a regulatory-ready software solution for connected medical devices including continuous glucose monitors (CGM), biosensors, and wearables. The platform is designed to help early- and growth-stage MedTech companies build, scale, and achieve regulatory compliance for their connected device software faster than developing in-house.
Is Sequenex a public or private company?
Sequenex is a private company. It is classified as unknown and is currently operating.
When was Sequenex founded?
Sequenex was founded in 2020. It employs 11 to 50 people.
Where is Sequenex based?
Sequenex is headquartered in San Diego, United States, in the North America region.
How does Sequenex make money?
One revenue line is on record: software Platform Licensing.
Who are Sequenex's main competitors?
Broad incumbents on record are Veeva Systems, MasterControl, IQVIA, Medidata Solutions (Dassault Systèmes) and Philips HealthSuite. Direct peers are Greenlight Guru and BrightInsight. Emerging players are ComplianceQuest and Qualio. Forma Medical Affairs (Regulatory Software Division) is listed as a regional player.
Does Sequenex have an API?
No public API is recorded for Sequenex.
What industry is Sequenex in?
Sequenex's product category is Medical Device Software (SaMD). Its primary akta.pro industry code is HLAGAKAM, Training & Competency Programs for GxP Compliance, with a secondary code of BPAHAIAL, Testing, Inspection, Certification & Commissioning (TICx) Technical Services. Its NAICS code is 541512 and its SIC code is 7371.